Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Novo Nordisk faces rising pressure as LLY launches Foundayo, a rival obesity pill, challenging Wegovy despite data suggesting NVO's edge in efficacy.

Go to News Site